<DOC>
	<DOCNO>NCT00913185</DOCNO>
	<brief_summary>The purpose study compare effectiveness two counter acne product subject moderate severity acne vulgaris . The two product compare study Acne Free `` Severe Acne Line '' manufacture University Medical Products , ProactivÂ® manufacture Guthy-Renker .</brief_summary>
	<brief_title>Comparison Study Topical Acne Regimens</brief_title>
	<detailed_description>You receive study drug 8 week study . No subject give placebo ( inactive substance ) treatment.The study drug ( counter acne medication ) previously test safe use establish . However , risk side effect know . In rare case allergy , side effect may life threatening.The common side effect study drug : 1 . Dry skin 2 . Peeling skin 3 . Red skin 4 . Burning tingle ( temporary )</detailed_description>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Subjects and/or subject ' legal guardian understand willing sign Informed Consent Form , Assent Form indicate , HIPAA Authorization Form . Subjects receive permission parent guardian participate study classify minor , age 18 year . Male female subject age 13 45 year generally good health , determine Medical History Form . Subjects moderatelysevere acne vulgaris face neck determine defined baseline lesion count ( see Definition : Acne Severity ) . Subjects complete Medical History Form . Subjects use oral acne medication 1 month prior start study , topical acne medication 1 week prior start study . Subjects agree use acne medication study except test material give . Subjects agree use makeup contains acne treatment additive , benzoyl peroxide , salicylic acid retinol . Subjects willing photograph videorecorded study visit willing sign photographic release form . Subjects exhibit dependability intelligence follow direction . Subjects pregnant lactating . Subjects know allergy cosmetic , toiletry , acne treatment product . Subjects sensitive ingredient test article . Subjects participate facial treatment study within 3 week study initiation . Subjects exhibit acute chronic dermatological , medical , and/or physical condition would preclude application test material and/or influence outcome study . Subjects unable sit quietly 15 minute acclimate ambient temperature humidity condition laboratory . Male subject full beard . Subjects stop usage oral acne mediation 1 month prior study start , topical acne medication 1 week prior study start . Subjects take routine high dosage antiinflammatory medication ( aspirin , ibuprofen ) . Subjects must use oral corticosteroid and/or oral immunosuppressive drug ( steroid inhaler decongestant nose drop and/or eye drop permit ) . Any condition Investigator determines subject could place undo risk .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Acne</keyword>
</DOC>